incidence rate x 100,000/year
|
|
- Brianne Pitts
- 5 years ago
- Views:
Transcription
1 Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European crude incidence to the EU-28 population at 2008 ** applying the European crude incidence to the EU-28 population at 2014 *** rates age-adjusted to the European standard population Crude incidence rate x 100,000/year 95% confidence interval Estimated new cases at 2008 in EU Estimated new cases at 2014 in EU (28)** Age-adjusted incidence rate x 100,000/year*** 95% confidence interval 1 R EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES ,251 2, R Squamous cell carcinoma with variants of nasal cavity and sinuses ,746 1, R Lymphoepithelial carcinoma of nasal cavity and sinuses R Undifferentiated carcinoma of nasal cavity and sinuses R Intestinal type adenocarcinoma of nasal cavity and sinuses R EPITHELIAL TUMOURS OF NASOPHARYNX R Squamous cell carcinoma with variants of nasopharynx R Papillary adenocarcinoma of nasopharynx R EPITHELIAL TUMOURS OF MAJOR SALIVARY GLANDS AND SALIVARY-GLAND TYPE ,962 7, R Epithelial tumours of major salivary glands ,809 4, R Salivary gland type tumours of head and neck ,153 2, C EPITHELIAL TUMOURS OF HYPOPHARYNX AND LARYNX ,681 32, R Squamous cell carcinoma with variants of hypopharynx ,334 6, R Squamous cell carcinoma with variants of larynx ,067 23, R EPITHELIAL TUMOURS OF OROPHARYNX ,616 16, R Squamous cell carcinoma with variants of oropharynx ,593 15, R EPITHELIAL TUMOURS OF ORAL CAVITY AND LIP ,923 24, R Squamous cell carcinoma with variants of oral cavity ,547 17, R Squamous cell carcinoma with variants of lip ,106 5, C EPITHELIAL TUMOURS OF OESOPHAGUS ,082 39, R Squamous cell carcinoma with variants of oesophagus ,802 17, R Adenocarcinoma with variants of oesophagus ,336 16, R Salivary gland type tumours of oesophagus R Undifferentiated carcinoma of oesophagus C EPITHELIAL TUMOURS OF STOMACH ,201 88, C Adenocarcinoma with variants of stomach ,963 71, R Squamous cell carcinoma with variants of stomach R Salivary gland-type tumours of stomach R Undifferentiated carcinoma of stomach ,054 1, R EPITHELIAL TUMOURS OF SMALL INTESTINE ,875 3, R Adenocarcinoma with variants of small intestine ,945 2, R Squamous cell carcinoma with variants of small intestine C EPITHELIAL TUMOUR OF COLON , , C Adenocarcinoma with variants of colon , , R Squamous cell carcinoma with variants of colon R Fibromixoma and low grade mucinous adenocarcinoma of the appendix C EPITHELIAL TUMOURS OF RECTUM ,550 91, C Adenocarcinoma with variants of rectum ,328 83,
2 2 R Squamous cell carcinoma with variants of rectum R EPITHELIAL TUMOURS OF ANAL CANAL ,799 5, R Squamous cell carcinoma with variants of anal canal ,054 4, R Adenocarcinoma with variants of anal canal ,268 1, R Paget's disease of anal canal C EPITHELIAL TUMOURS OF PANCREAS ,635 65, C Adenocarcinoma with variants of pancreas ,849 40, R Squamous cell carcinoma with variants of pancreas R Acinar cell carcinoma of pancreas R Mucinous cystadenocarcinoma of pancreas R Intraductal papillary mucinous carcinoma invasive of pancreas R Solid pseudopapillary carcinoma of pancreas R Serous cystadenocarcinoma of pancreas R Carcinoma with osteoclast-like giant cells of pancreas C EPITHELIAL TUMOURS OF LIVER AND INTRAEPATIC BILE TRACT (IBT) ,545 36, R Hepatocellular carcinoma of Liver and IBT ,119 16, R Hepatocellular carcinoma, fibrolamellar of liver and IBT R Cholangiocarcinoma of IBT ,856 4, R Adenocarcinoma with variants of liver and IBT ,063 2, R Undifferentiated carcinoma of liver and IBT R Squamous cell carcinoma with variants of liver and IBT R Bile duct cystadenocarcinoma of IBT R EPITHELIAL TUMOURS OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT (EBT) ,230 22, R Adenocarcinoma with variants of gallbladder ,735 6, R Adenocarcinoma with variants of EBT ,191 7, R Squamous cell carcinoma of gallbladder and EBT R EPITHELIAL TUMOUR OF TRACHEA R Squamous cell carcinoma with variants of trachea R Adenocarcinoma with variants of trachea R Salivary gland type tumours of trachea C EPITHELIAL TUMOUR OF LUNG , , C Squamous cell carcinoma with variants of lung ,579 62, C Adenocarcinoma with variants of lung ,194 59, R Adenosquamous carcinoma of lung ,472 1, R Large cell carcinoma of lung ,075 19, C Poorly differentiated endocrine carcinoma of lung ,575 40, R Salivary gland type tumours of lung R Sarcomatoid carcinoma of lung ,040 1, R EPITHELIAL TUMOURS OF THYMUS R Malignant thymoma R Squamous cell carcinoma of thymus R Undifferentiated carcinoma of thymus R Lymphoepithelial carcinoma of thymus R Adenocarcinoma with variants of thymus C EPITHELIAL TUMOURS OF BREAST , , C Invasive ductal carcinoma of breast , ,
3 2 C Invasive lobular carcinoma of breast ,798 39, R Mammary Paget s disease of breast ,073 2, R Special types of adenocarcinoma of breast ,337 15, R Metaplastic carcinoma of breast R Salivary gland type tumours of breast R Epithelial tumour of male breast ,301 5, C EPITHELIAL TUMOURS OF CORPUS UTERI ,791 57, C Adenocarcinoma with variants of corpus uteri ,689 50, R Squamous cell carcinoma with variants of corpus uteri R Adenoid cystic carcinoma of corpus uteri R Clear cell adenocarcinoma, not otherwise specified of corpus uteri R Serous (papillary) carcinoma of corpus uteri R Mullerian mixed tumour of corpus uteri ,005 2, C EPITHELIAL TUMOURS OF CERVIX UTERI ,408 31, R Squamous cell carcinoma with variants of cervix uteri ,672 24, R Adenocarcinoma with variants of cervix uteri ,553 4, R Undifferentiated carcinoma of cervix uteri R Mullerian mixed tumour of cervix uteri C EPITHELIAL TUMOUR OF OVARY AND FALLOPPIAN TUBE ,929 47, R Adenocarcinoma with variants of ovary ,792 30, R Mucinous adenocarcinoma of ovary ,854 3, R Clear cell adenocarcinoma of ovary ,518 1, R Primary peritoneal serous/papillary carcinoma of ovary R Mullerian mixed tumour of ovary R Adenocarcinoma with variant of falloppian tube R NON EPITHELIAL TUMOURS OF OVARY ,270 1, R Sex cord tumours of ovary R Malignant/Immature teratomas of ovary R Germ cell tumour of ovary R EPITHELIAL TUMOURS OF VULVA AND VAGINA ,883 10, R Squamous cell carcinoma with variants of vulva and vagina ,440 8, R Adenocarcinoma with variants of vulva and vagina R Paget s disease of vulva and vagina R Undifferentiated carcinoma of vulva and vagina R TROPHOBLASTIC TUMOUR OF PLACENTA R Choriocarcinoma of placenta C EPITHELIAL TUMOURS OF PROSTATE , , C Adenocarcinoma with variants of prostate , , R Squamous cell carcinoma with variants of prostate R Infiltrating duct carcinoma of prostate ,576 2, R Transitional cell carcinoma of prostate R Salivary gland type tumours of prostate R TESTICULAR AND PARATESTICULAR CANCERS ,486 16, R Paratesticular adenocarcinoma with variants R Non seminomatous testicular cancer ,336 6, R Seminomatous testicular cancer ,109 9,
4 2 R Spermatocytic seminoma R Teratoma with malignant transformation R Testicular sex cord cancer R EPITHELIAL TUMOURS OF PENIS ,312 3, R Squamous cell carcinoma with variants of penis ,081 3, R Adenocarcinoma with variants of penis C EPITELIAL TUMOURS OF KIDNEY ,589 64, C Renal cell carcinoma with variants ,436 51, R Squamous cell carcinoma spindle cell type of kidney R Squamous cell carcinoma with variants of kidney R EPITHELIAL TUMOURS OF PELVIS AND URETER ,930 8, R Transitional cell carcinoma of pelvis and ureter ,059 7, R Squamous cell carcinoma with variants of pelvis and ureter R Adenocarcinoma with variants of pelvis and ureter R EPITHELIAL TUMOURS OF URETHRA R Transitional cell carcinoma of urethra R Squamous cell carcinoma with variants of urethra R Adenocarcinoma with variants of urethra C EPITHELIAL TUMOURS OF BLADDER ,080 92, C Transitional cell carcinoma of bladder ,481 79, R Squamous cell carcinoma with variants of bladder ,778 1, R Adenocarcinoma with variants of bladder ,486 1, R Salivary gland type tumours of bladder R EPITHELIAL TUMOURS OF EYE AND ADNEXA R Squamous cell carcinoma with variants of eye and adnexa R Adenocarcinoma with variants of eye and adnexa R EPITHELIAL TUMOURS OF MIDDLE EAR R Squamous cell carcinoma with variants middle ear R Adenocarcinoma with variants of middle ear R MALIGNANT MESOTHELIOMA ,718 10, R Mesothelioma of pleura and pericardium ,160 9, R Mesothelioma of peritoneum and tunica vaginalis C MALIGNANT SKIN MELANOMA ,343 71, C Malignant skin melanoma ,343 71, R MALIGNANT MELANOMA OF MUCOSA R Malignant melanoma of mucosa R MALIGNANT MELANOMA OF UVEA ,521 3, R Malignant melanoma of uvea ,521 3, C EPITHELIAL TUMOURS OF SKIN , , C Basal cell carcinoma of skin , , C Squamous cell carcinoma with variants of skin ,456 72, R ADNEXAL CARCINOMA OF SKIN ,496 1, R Adnexal carcinoma of skin ,496 1, R NEUROBLASTOMA AND GANGLIONEUROBLASTOMA R Neuroblastoma e ganglioneuroblastoma R NEPHROBLASTOMA
5 2 R Nephroblastoma R RETINOBLASTOMA R Retinoblastoma R HEPATOBLASTOMA R Heatoblastoma R PLEUROPULMONARY BLASTOMA R Pleuropulmonary blastoma R PANCREATOBLASTOMA R Pancreatoblastoma R OLFACTORY NEUROBLASTOMA R Olfactory neuroblastoma R ODONTOGENIC MALIGNANT TUMOURS R Odontogenic malignant tumours R EXTRAGONADAL GERM CELL TUMOURS R Non seminomatous germ cell tumours R Seminomatous germ cell tumors R Germ cell tumors of Central Nervous System (CNS) R SOFT TISSUE SARCOMA ,574 23, R Soft tissue sarcoma of head and neck ,306 1, R Soft tissue sarcoma of limbs ,487 5, R Soft tissue sarcoma of superficial trunk ,496 2, R Soft tissue sarcoma of mediastinum R Soft tissue sarcoma of heart R Soft tissue sarcoma of breast R Soft tissue sarcoma of uterus ,765 2, R Other soft tissue sarcomas of genitourinary tract ,009 1, R Soft tissue sarcoma of viscera ,918 1, R Soft tissue sarcoma of paratestis R Soft tissue sarcoma of retroperitoneum and peritoneum ,569 1, R Soft tissue sarcoma of pelvis , R Soft tissue sarcoma of skin ,513 1, R Soft tissue sarcoma of paraorbit R Soft tissue sarcoma of brain and other parts of nervous system R Embryonal rhabdomyosarcoma of soft tissue R Alveolar rhabdomyosarcoma of soft tissue R Ewing s sarcoma of soft tissue R BONE SARCOMA ,273 4, R Osteogenic sarcoma ,064 1, R Chondrogenic sarcomas ,312 1, R Notochordal sarcomas, chordoma R Vascular sarcomas R Ewing s sarcoma R Epithelial tumours, adamantinoma R Other high grade sarcomas (fibrosarcoma, malignant fibrous histiocytoma) R GASTROINTESTINAL STROMAL SARCOMA ,503 1, R Gastrointestinal stromal sarcoma ,503 1,
6 1 R KAPOSI'S SARCOMA ,244 1, R Kaposi's sarcoma ,244 1, R NEUROENDOCRINE TUMOURS ,551 17, R Well differentiated not functing endocrine carcinoma of pancreas and digestive system ,064 5, R Well differentiated functing endocrine carcinoma of pancreas and digestive system R Poorly differentiated endocrine carcinoma of pancreas and digestive system ,329 3, R Mixed endocrine-exocrine carcinoma of pancreas and digestive system R Endocrine carcinoma of thyroid gland ,213 1, R Neuroendocrine carcinoma of skin R Typical and atypical carcinoid of the lung ,968 1, R Neuroendocrine carcinoma of other sites ,511 4, R Pheochromocytoma, malignant R Paraganglioma R CARCINOMAS OF PITUITARY GLAND R Carcinoma of pituitary gland R CARCINOMAS OF THYROID GLAND ,370 25, R Carcinoma of thyroid gland ,370 25, R CARCINOMAS OF PARATHYROID GLAND R Carcinoma of parathyroid gland R CARCINOMA OF ADRENAL GLAND ,094 1, R Carcinoma of adrenal gland ,094 1, C TUMOURS OF CENTRAL NERVOUS SYSTEM (CNS) ,828 37, R Astrocytic tumours of CNS ,954 25, R Oligodendroglial tumours of CNS ,964 1, R Ependymal tumours of CNS ,026 1, R Neuronal and mixed neuronal-glial tumors R Choroid plexus carcinoma of CNS R Malignant meningiomas R EMBRYONAL TUMORS OF CENTRAL NERVOUS SYSTEM (CNS) , R Embryonal tumors of CNS , C LYMPHOID DISEASES , , R Hodgkin lymphoma, classical ,327 12, R Hodgkin lymphoma nodular lymphocyte predominance R Precursor B/T lymphoblastic leuk/lymphoma (and Burkitt leukemia/lymphoma) ,282 7, R T cutaneous lymphoma (Sezary syn, Mycosis fung) ,765 1, R Other T cell lymphomas and NK cell neoplasms ,085 3, R Diffuse B lymphoma ,609 21, R Follicular B lymphoma ,972 11, R Hairy cell leukaemia ,398 1, R Plasmacytoma/Multiple Myeloma (and Heavy chain diseases) ,571 28, C Other non Hodgkin, Mature B cell lymphoma ,858 32, R Mantle cell lymphoma ,794 2, R Prolymphocytic leukaemia, B cell R ACUTE MYELOID LEUKEMIA AND RELATED PRECURSOR NEOPLASMS ,041 19, R Acute promyelocytic leukemia (AML) with t(15;17) with variants R Acute myeloid leukemia ,502 17,
7 1 R MYELOPROLIFERATIVE NEOPLASMS ,575 16, R Chronic myeloid leukemia ,582 5, R Other myeloproliferative neoplasms ,846 10, R Mast cell tumour R MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE ,375 12, R Myelodysplastic syndrome with 5q syndrome R Other myelodysplastic syndrome ,715 10, R Chronic Myelomonocytic leukemia ,451 1, R Atypical chronic myeloid leukemia BCR/ABL negative R HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS R Histiocytic malignancies R Lymph node accessory cell tumors
ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
More informationRARECARENet country report Bulgaria
RARECARENet country report Bulgaria 26 April 2016 Contents 1. Introduction... 3 2. The epidemiology of rare cancers in Bulgaria... 4 3. Quality indicators for centres of expertise for rare cancers... 5
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
More informationMethoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationHOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationRare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
More informationLayer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
More information155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
More informationSHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
More informationChapter 4. Histological groups
Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based
More informationSUPPLEMENTARY INFORMATION
Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent
More informationCLIC Sargent Eligibility Criteria
1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd
More informationCANCER REGISTRY 2004
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
More informationCODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
More informationRadiation Oncology Study Guide
Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationChapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationCANCER REGISTRY 2002
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
More informationANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
More informationSEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
More informationAnnual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
More informationCancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
More informationAppendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
More informationANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
More informationOncology Centre Research Unit TUMOR REGISTRY
1 Oncology Centre Research Unit TUMOR REGISTRY ANNUAL REPORT 2013 1 Annual Report Prepared by the Staff of the Tumor Registry Research Unit, Oncology Centre King Faisal Specialist Hospital and Research
More informationChecklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
More informationACR TXIT TM EXAM OUTLINE
ACR TXIT TM EXAM OUTLINE Major Domain Sub-Domain 1 Statistics 1.1 Study design 1.2 Definitions of statistical terms 1.3 General interpretation & analysis 1.4 Survival curves 1.5 Specificity/sensitivity
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationFlorida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
More informationThe European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
More informationCancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
More informationANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More informationRare Tumours of Male Genital Organs
Rare Tumours of Male Genital Organs 1. Epithelial Tumours of Prostate 1.1 General Results Table 1. Epithelial Tumours of Prostate: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival
More informationCancer survival in Seoul, Republic of Korea,
Cancer survival in Seoul, Republic of Korea, 1993 1997 Ahn YO and Shin MH Abstract The Seoul cancer registry was established in 1991. Cancer is a notifiable disease, and registration of cases is done by
More information2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
More informationCHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward Published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More information82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung
82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea
More informationEffective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
More informationEffective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More information2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More information2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%
Appendix A Training Centre Accreditation Checklist A. Accreditation of the HOSPITAL 1. Total number of beds in the hospital : Minimum 500 beds 2. Occupancy rate of beds in the hospital: Occupancy rate
More informationOther Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
More informationTable of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3
Table of Contents Preface xi Acknowledgments xiii Part I Overview of the Diagnostic Process 1 1 Overview of Grading and Staging 3 Identification of the process 3 Identification of tumor types 5 Grading
More informationChapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
More information2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
More informationContractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)
Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor
More information2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
More informationCancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
More informationCancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
More informationEPITHELIAL TUMOURS OF OESOPHAGUS RARE EPITHELIAL TUMOURS OF STOMACH EPITHELIAL TUMOURS OF SMALL INTESTINE RARE EPITHELIAL TUMOURS OF COLON
RARE EPITHELIAL TUMOURS OF THE DIGESTIVE SYSTEM 16% OF DIGESTIVE SYSTEM TUMOURS ARE RARE EPITHELIAL TUMOURS 2 262 271 EPITHELIAL TUMOURS OF OESOPHAGUS RARE EPITHELIAL TUMOURS OF STOMACH 81 1 % OF RARE
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More information2012 Cancer Report 2011 Registry Data
2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency
More informationA Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer
More informationCancer Program Report 2014
Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167
More informationResearch Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2014, Article ID 437971, 18 pages http://dx.doi.org/10.1155/2014/437971 Research Article Cancer Incidence in Egypt: Results of the National
More informationAll Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
More informationCancer in Central and South America BOLIVIA
Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers
More informationGroup B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green
Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth
More informationAppendix A: Definitions for Cancer Incidence Data
Appendices Cancer in Minnesota, 1988-2002 231 Appendix A: Definitions for Cancer Incidence Data MCSS collects information on all microscopically confirmed malignant and in situ tumors diagnosed in Minnesota
More informationCancer in Colorado Incidence, Mortality, and Survival
Cancer in Colorado 1998-2003 Incidence, Mortality, and Survival Jack L. Finch, M.S. Statistical Analyst III Kieu O. Vu, M.S.P.H. Statistical Analyst II 2007 Colorado Central Cancer Registry Randi K. Rycroft,
More informationNeoplasms/Lymphoma/Leukemia
Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationGlobally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample
More informationHuman cell line list Production of Exosome Standards - Cell Lysates
Human cell line list 2016 - Production of Exosome Standards - Cell Lysates 380 peripheral blood leukemia, pre-b cell 1301 blood leukemia, acute lymphoblastic, T cell 5637 bladder carcinoma 8305C thyroid
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationCancer Incidence in Sweden 1998
STATISTICS HEALTH AND DISEASES 2000:4 Cancer Incidence in Sweden 1998 CENTRE FOR EPIDEMIOLOGY SVERIGES OFFICIELLA STATISTIK OFFICIAL STATISTICS OF SWEDEN Statistics - Health and Diseases Cancer Incidence
More informationClinical Coding for CRS Standards
Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th
More informationEND-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER
University of Szeged, Faculty of Medicine Department of Anatomy, Histology and Embryology Chairman: Prof. Antal Nógrádi MD, PhD, DSc Kossuth L. sgt. 40., H-6724 Szeged, Hungary Tel.: +36-62-545-665 P.
More informationInterventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies
Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/
More information2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification
More informationDiagnostic IHC in lung and pleura pathology
Diagnostic IHC in lung and pleura pathology Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark WHO 2004 and Web Malignant mesothelioma Epithelioid
More informationComprehensive Cancer Cover
Comprehensive Cancer Cover Tech Spec Comprehensive Cancer Cover provides the life insured with cover for the diagnosis and treatment of defined malignant tumours. These tumours must be characterised either
More informationModel Policy. Coverage of Proton Therapy
Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique
More informationSupplementary Online Content
Supplementary Online Content Chacón MR, Enrico DH, Burton J, Waisberg FD, Videla VM. Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published February 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR
More informationAMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING
AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING ATLAS EDITORS FREDERICK L. GREENE, m.d. Chair, Department of General Surgery Carolinas Medical Center Charlotte, North Carolina CAROLYN C. COMPTON,
More informationSuggested citation Thursfield V, Farrugia H. Cancer in Victoria: Statistics & Trends Cancer Council Victoria, Melbourne 2016
CANCER IN VICTORIA STATISTICS & TRENDS 2015 Cancer Council Victoria 2016 November 2016, Cancer Council Victoria, Melbourne Editors: Vicky Thursfield and Helen Farrugia Suggested citation Thursfield V,
More informationSerum Iron Studies
190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient
More informationAJCC 7th Edition Handbook Errata as of 9/21/10
5 81 Larynx ICD-O-3 Topography Codes Delete C32.3 Laryngeal cartilage 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.8 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.9 5
More informationMacmillan Publications
S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer
More informationSupplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.
SUPPLEMENTARY MATERIALS Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.0) Basket preferred term 5q minus
More informationRAMATHIBODI CANCER REPORT
RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationFINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
More informationWhat is the problem, and how big is it?
Rare cancers What is the problem, and how big is it? Rare (orphan) diseases NIH Office for Rare Diseases Prevalence less than 5/10 000 in the community In the US
More informationCHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
More informationComprehensive cancer cover
Retirement Investments Insurance Health Comprehensive cancer cover Life Insurance+ with critical illness and Critical Illness+ Cancer is one of the biggest fears for the British public This is why our
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationMALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS
MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary
More information